目的 觀察胃腸安丸聯(lián)合蒙脫石散治療食滯胃腸證急性腹瀉的臨床療效。方法 選取2012年5月-2016年10月天津中醫(yī)藥大學第一附屬醫(yī)院收治的食滯胃腸證急性腹瀉患者60例，隨機分為對照組（29例）和治療組（31例）。對照組口服蒙脫石散，1袋/次，3次/d；治療組在對照組的基礎上口服胃腸安丸，4丸/次，3次/d，兩組患者均連續(xù)治療3 d。評價兩組患者臨床療效，同時比較治療前后兩組患者中醫(yī)證侯評分差異。結(jié)果 治療后，對照組和治療組臨床有效率分別為86.21%和93.55%，兩組比較差異無統(tǒng)計學意義。治療后，兩組排便頻率、糞便性狀、納呆、脘腹痞滿等方面評分顯著降低，同組比較差異具有統(tǒng)計學意義（P<0.05）。治療后，治療組腹脹、腹痛、噯氣吞酸、舌苔厚膩方面評分明顯低于對照組，兩組比較差異有統(tǒng)計學意義（P<0.05），同時治療組在這些方面評分比治療前顯著降低（P<0.05）。治療后，治療組納呆、脘腹痞滿方面評分明顯低于對照組，兩組比較差異具有統(tǒng)計學意義（P<0.05）。結(jié)論 胃腸安丸聯(lián)合蒙脫石散治療食滯胃腸型急性腹瀉在改善中醫(yī)證侯方面，顯示出獨特的優(yōu)勢，具有一定的臨床推廣應用價值。

Objective To observe the clinical efficacy of Clinical observation of Weichang'an Pills combined with Montmorillonite Powder in treatment of acute diarrhea of dyspeptic retention gastroenteric disease. Methods Patients (60 cases) with acute diarrhea of dyspeptic retention gastroenteric disease in the First Teaching Hospital of Tianjin University of TCM from May 2012 to October 2016 were randomly divided into control (29 cases) and treatment (31 cases) groups. Patients in the control group were po administered with Montmorillonite Powder, 1 bag/time, three times daily. Patients in the treatment group were po administered with Weichang'an Pills on the basis of the control group, 4 pills/time, three times daily. Patients in two groups were treated for 3 d. After treatment, the clinical efficacy was evaluated, the TCM syndrome scores in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control and treatment groups were 86.21% and 93.55% respectively, and there were no differences between two groups. After treatment, the defecation frequency, fecal property, anorexia, abdominal fullness and distention scores in two groups were significantly decreased, and the difference was statistically significant in the same group (P<0.05). After treatment, the abdominal distension and pain, belching and swallowing acid, thick and greasy fru of the tongue scores in the treatment group after treatment were significantly lower than those in the control group, with significant difference between two groups (P<0.05), and these scores in the treatment group after treatment were significantly decreased, and there were differences in the same group (P<0.05). After treatment, the anorexia, abdominal fullness and distention scores in the treatment group after treatment were significantly lower than those in the control group, with significant difference between two groups (P<0.05). Conclusion Weichang'an Pills combined with Montmorillonite Powder in treatment of acute diarrhea of dyspeptic retention gastroenteric disease has distinctive therapeutic advantage in improving the TCM syndrome, which has a certain clinical application value.